Press Releases

• Active Biotech Year End Report 2022
  Feb 9, 2023 08:30 (CET) Regulatory
• Active Biotech confirms positive clinical safety profile of laquinimod eye drops
  Jan 30, 2023 08:30 (CET) Regulatory
• Preclinical data with tasquinimod in MDS presented at ASH 2022 available on Active Biotech’s website
  Dec 13, 2022 15:00 (CET)
• Active Biotech’s nomination committee appointed
  Dec 5, 2022 15:00 (CET) Regulatory
• Preclinical data with tasquinimod in MDS to be presented at ASH 2022
  Nov 3, 2022 15:00 (CET)